Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason N Cole

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Scientific Reports|February 22, 2017
Group A Streptococcal M1 Protein Provides Resistance against the Antimicrobial Activity of HistonesSimon Döhrmann, Christopher N LaRock, Ericka L Anderson, et al.
Clinical Microbiology Reviews|April 4, 2014
Disease manifestations and pathogenic mechanisms of Group A StreptococcusMark J Walker, Timothy C Barnett, Jason D McArthur, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 29, 2015
Host and pathogen hyaluronan signal through human siglec-9 to suppress neutrophil activationIsmael Secundino, Anel Lizcano, K Markus Roupé, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 31, 2008
Allelic variants of streptokinase from Streptococcus pyogenes display functional differences in plasminogen activationJason D McArthur, Fiona C McKay, Vidiya Ramachandran, et al.
Proteomics|December 12, 2007
Role of group A Streptococcus HtrA in the maturation of SpeB proteaseJason N Cole, John A Aquilina, Peter G Hains, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 28, 2013
Streptococcal collagen-like protein A and general stress protein 24 are immunomodulating virulence factors of group A StreptococcusJames A Tsatsaronis, Andrew Hollands, Jason N Cole, et al.
Antimicrobial Agents and Chemotherapy|August 9, 2021
Development of Novel Immunoprophylactic Agents against Multidrug-Resistant Gram-Negative Bacterial InfectionsArianne Lovey, Mila Krel, Allen Borchardt, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 23, 2006
Trigger for group A streptococcal M1T1 invasive diseaseJason N Cole, Jason D McArthur, Fiona C McKay, et al.
Nature Medicine|July 17, 2007
DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infectionMark J Walker, Andrew Hollands, Martina L Sanderson-Smith, et al.
Vaccines|April 27, 2024
Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A <i>Streptococcus</i> Pharyngeal Infection in a Non-Human Primate ModelTania Rivera-Hernandez, Diane G Carnathan, Johanna Richter, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Scientific Reports|February 22, 2017
Group A Streptococcal M1 Protein Provides Resistance against the Antimicrobial Activity of HistonesSimon Döhrmann, Christopher N LaRock, Ericka L Anderson, et al.
Clinical Microbiology Reviews|April 4, 2014
Disease manifestations and pathogenic mechanisms of Group A StreptococcusMark J Walker, Timothy C Barnett, Jason D McArthur, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 29, 2015
Host and pathogen hyaluronan signal through human siglec-9 to suppress neutrophil activationIsmael Secundino, Anel Lizcano, K Markus Roupé, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 31, 2008
Allelic variants of streptokinase from Streptococcus pyogenes display functional differences in plasminogen activationJason D McArthur, Fiona C McKay, Vidiya Ramachandran, et al.
Proteomics|December 12, 2007
Role of group A Streptococcus HtrA in the maturation of SpeB proteaseJason N Cole, John A Aquilina, Peter G Hains, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 28, 2013
Streptococcal collagen-like protein A and general stress protein 24 are immunomodulating virulence factors of group A StreptococcusJames A Tsatsaronis, Andrew Hollands, Jason N Cole, et al.
Antimicrobial Agents and Chemotherapy|August 9, 2021
Development of Novel Immunoprophylactic Agents against Multidrug-Resistant Gram-Negative Bacterial InfectionsArianne Lovey, Mila Krel, Allen Borchardt, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 23, 2006
Trigger for group A streptococcal M1T1 invasive diseaseJason N Cole, Jason D McArthur, Fiona C McKay, et al.
Nature Medicine|July 17, 2007
DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infectionMark J Walker, Andrew Hollands, Martina L Sanderson-Smith, et al.
Vaccines|April 27, 2024
Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A <i>Streptococcus</i> Pharyngeal Infection in a Non-Human Primate ModelTania Rivera-Hernandez, Diane G Carnathan, Johanna Richter, et al.
Pageof 4